You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

enhanced immunotherapy

Showing 1 - 25 of 7,726
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Glioblastoma Trial in Beijing (Combined stereotactic radiosurgery and enhanced immunotherapy)

Recruiting
  • Recurrent Glioblastoma
  • Combined stereotactic radiosurgery and enhanced immunotherapy
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Nov 16, 2021

Prognosis of Lung Cancer Immunotherapy

Not yet recruiting
  • Lung Cancer
    • (no location specified)
    May 31, 2023

    Triple Negative Breast Cancer Trial in Birmingham ([18F]FMISO-PET with contrast-enhanced MRI)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • [18F]FMISO-PET with contrast-enhanced MRI
    • Birmingham, Alabama
      UAB
    Nov 15, 2022

    Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early

    Recruiting
    • Metastatic Breast Cancer in the Liver
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Sep 23, 2022

    Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Palo Alto (Doppler ultrasound, Long Ensemble Angular-coherence

    Recruiting
    • Renal Cell Carcinoma
    • Metastatic Renal Cell Carcinoma
    • Doppler ultrasound
    • +2 more
    • Palo Alto, California
      Stanford
    Mar 22, 2022

    Breast Cancer, Breast Tumors Trial in Portland (Pembrolizumab, IRX 2)

    Recruiting
    • Breast Cancer
    • Breast Neoplasms
    • Portland, Oregon
      Providence Portland Medical Center
    Jan 31, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Adenocarcinoma, Metastatic Breast Carcinoma Trial in

    Withdrawn
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +4 more
    • Bintrafusp Alfa
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 2, 2022

    Hepatocellular Cancer, AFP Expressing Tumors Trial in Worldwide (Autologous genetically modified AFP?³³²T cells)

    Active, not recruiting
    • Hepatocellular Cancer
    • AFP Expressing Tumors
    • Autologous genetically modified AFPᶜ³³²T cells
    • Phoenix, Arizona
    • +20 more
    Aug 26, 2022

    Cancer Patients Trial in Jinan (At the same time, the original regimen of immunomaintenance therapy was continued, according to

    Recruiting
    • Cancer Patients
    • At the same time, the original regimen of immunomaintenance therapy was continued, according to the frequency of the original immunization regimen once every 3 weeks until progress.
    • Jinan, In Shandong Province, China
      The First Affiliated Hospital of Shandong First Medical Universi
    Sep 16, 2022

    Immune Profiling for Cancer Immunotherapy Response

    Recruiting
    • Cancer
    • +3 more
    • Methylation Cytometry
    • Lebanon, New Hampshire
      Dartmouth-Hitchcock Medical Center
    Nov 6, 2023

    Colon Tumor Trial in Hangzhou (Oxaliplatin, Capecitabine, Anti-PD-L1 Monoclonal Antibody)

    Not yet recruiting
    • Colon Neoplasm
    • Hangzhou, Zhejiang, China
      Second Affiliated Hospital of Zhejiang University School of Medi
    Jun 25, 2023

    Cancer Patients Trial in Jinan (Low-dose radiotherapy combined with conventional fractionated radiotherapy)

    Recruiting
    • Cancer Patients
    • Low-dose radiotherapy combined with conventional fractionated radiotherapy
    • Jinan, In Shandong Province, China
      The First Affiliated Hospital of Shandong First Medical Universi
    Jun 7, 2023

    Non Small Cell Lung Cancer Trial in Changsha (radiotherapy, Chemotherapy + immunotherapy)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • radiotherapy
    • Chemotherapy + immunotherapy
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Oct 17, 2022

    Colon Cancer, Neoadjuvant Therapy, Immunotherapy Trial in Guangzhou (Envafolimab, CAPEOX)

    Recruiting
    • Colon Cancer
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-Sen University Cancer Center
    Aug 26, 2023

    Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Tremelimumab, Yttrium-90 radioembolisation)

    Recruiting
    • Hepatocellular Carcinoma
    • Hong Kong, Hong Kong
      Department of Clinical Oncology, Queen Mary Hospital
    Apr 10, 2023

    Metastatic Colorectal Cancer Trial in Køge (Irreversible electroporation, Calcium electroporation, Pembrolizumab)

    Recruiting
    • Metastatic Colorectal Cancer
    • Irreversible electroporation
    • +2 more
    • Køge, Denmark
      Zealand University Hospital
    Jan 27, 2023

    Small Cell Lung Carcinoma Trial in Milano (Cyclic, 5-day calorie restriction, Atezolizumab)

    Not yet recruiting
    • Small Cell Lung Carcinoma
    • Milano, Italy
      Fondazione IRCCS Istituto Nazionale Tumori
    Jan 19, 2023

    Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB

    Recruiting
    • Non Small Cell Lung Cancer
    • anti-PD-1 or anti-PD-L1
    • +2 more
    • Shanghai, China
      Oncology Department, Shanghai Chest Hospital
    Jul 26, 2022

    Cancer-related Problem/Condition, Exercise, Acupressure Trial in Baltimore (Technology Enhanced Home Exercise (TEHE), Auricular

    Recruiting
    • Cancer-related Problem/Condition
    • +2 more
    • Technology Enhanced Home Exercise (TEHE)
    • +2 more
    • Baltimore, Maryland
      The Sidney Kimmel Comprehensive Cancer Center
    Sep 16, 2022

    Metastatic Renal Cell Carcinoma, Metastatic Clear-cell Renal Cancer, Recurrent Renal Cell Carcinoma Trial in Iowa City,

    Completed
    • Metastatic Renal Cell Carcinoma
    • +4 more
    • HyperAcute®-Renal (HAR) Immunotherapy
    • Iowa City, Iowa
    • +2 more
    Apr 4, 2022

    Glioma, Malignant, High Grade Glioma, Glioblastoma Trial in Tampa (OS2966, Gadoteridol)

    Active, not recruiting
    • Glioma, Malignant
    • +4 more
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 28, 2022

    Advanced Malignant Solid Tumor Trial in Houston (Interview, Palliative Therapy, Quality-of-Life Assessment)

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • Interview
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 4, 2021

    MDR-TB, Immunotherapy Trial in Shanghai (V?2Vd2 T lymphocyte-based immunotherapy, Treatment regimens for MDR-TB)

    Recruiting
    • MDR-TB
    • Immunotherapy
    • Vγ2Vδ2 T lymphocyte-based immunotherapy
    • Treatment regimens for MDR-TB
    • Shanghai, China
    • +1 more
    Aug 8, 2022

    High-Risk Localized Soft Tissue Sarcoma Trial in Shanghai (Pegylated Liposomal Doxorubicin, Doxorubicin, Anti-PD-1 mAb)

    Recruiting
    • High-Risk Localized Soft Tissue Sarcoma
    • Pegylated Liposomal Doxorubicin
    • +3 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Mar 15, 2023

    Endometrial Cancer Trial in United States (Facilitated group support, 1:1 Peer Support)

    Recruiting
    • Endometrial Cancer
    • Facilitated group support
    • 1:1 Peer Support
    • Little Rock, Arkansas
    • +6 more
    Oct 26, 2022